1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Advanced Wound Care Management Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Advanced Wound Care Management Market Analysis and Forecast, 2023–2031
5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Product/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Advanced Wound Care Management Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product Type, 2023–2031
        6.3.1. Moist Wound Dressings
            6.3.1.1. Foam Dressings
            6.3.1.2. Hydrocolloid Dressings
            6.3.1.3. Hydrogel Dressings
            6.3.1.4. Alginate Dressings
            6.3.1.5. Collagen Dressings
            6.3.1.6. Others
        6.3.2. Antimicrobial Dressings
            6.3.2.1. Silver Dressings
            6.3.2.2. Non-silver Dressings
        6.3.3. Active Wound Care
            6.3.3.1. Artificial Skin Substitutes
            6.3.3.2. Autografts
            6.3.3.3. Growth Factors
        6.3.4. Therapy Devices
            6.3.4.1. Negative Pressure Wound Therapy
            6.3.4.2. Oxygen and Hyperbaric Oxygen Equipment
            6.3.4.3. Pressure Relief Devices
            6.3.4.4. Electromagnetic Therapy Devices
            6.3.4.5. Others
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Advanced Wound Care Management Market Analysis and Forecast, by Wound Type
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Wound Type, 2023–2031
        7.3.1. Acute Wound
            7.3.1.1. Surgical & Traumatic Wounds
            7.3.1.2. Burns
        7.3.2. Chronic Wound
            7.3.2.1. Infectious Wounds & Other Ischemic Wounds
            7.3.2.2. Ulcers
                7.3.2.2.1. Pressure Ulcer
                7.3.2.2.2. Diabetic Foot Ulcer
                7.3.2.2.3. Arterial & Venous Ulcer
                7.3.2.2.4. Other Ulcers
    7.4. Market Attractiveness Analysis, by Wound Type
8. Global Advanced Wound Care Management Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2023–2031
        8.3.1. Hospitals & Clinics
        8.3.2. Ambulatory Surgical Centers (ASCs)
        8.3.3. Home Health Care
        8.3.4. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global Advanced Wound Care Management Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2023–2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Advanced Wound Care Management Market Analysis and Forecast
    10.1. Introduction
    10.2. Key Findings
    10.3. Market Value Forecast, by Product Type, 2023–2031
        10.3.1. Moist Wound Dressings
            10.3.1.1. Foam Dressings
            10.3.1.2. Hydrocolloid Dressings
            10.3.1.3. Hydrogel Dressings
            10.3.1.4. Alginate Dressings
            10.3.1.5. Collagen Dressings
            10.3.1.6. Others
        10.3.2. Antimicrobial Dressings
            10.3.2.1. Silver Dressings
            10.3.2.2. Non-silver Dressings
        10.3.3. Active Wound Care
            10.3.3.1. Artificial Skin Substitutes
            10.3.3.2. Autografts
            10.3.3.3. Growth Factors
        10.3.4. Therapy Devices
            10.3.4.1. Negative Pressure Wound Therapy
            10.3.4.2. Oxygen and Hyperbaric Oxygen Equipment
            10.3.4.3. Pressure Relief Devices
            10.3.4.4. Electromagnetic Therapy Devices
            10.3.4.5. Others
    10.4. Market Value Forecast, by Wound Type, 2023–2031
        10.4.1. Acute Wound
            10.4.1.1. Surgical & Traumatic Wounds
            10.4.1.2. Burns
        10.4.2. Chronic Wound
            10.4.2.1. Infectious Wounds & Other Ischemic Wounds
            10.4.2.2. Ulcers
                10.4.2.2.1. Pressure Ulcer
                10.4.2.2.2. Diabetic Foot Ulcer
                10.4.2.2.3. Arterial & Venous Ulcer
                10.4.2.2.4. Other Ulcers
    10.5. Market Value Forecast, by End-user, 2023–2031
        10.5.1. Hospitals & Clinics
        10.5.2. Ambulatory Surgical Centers (ASCs)
        10.5.3. Home Health Care
        10.5.4. Others
    10.6. Market Value Forecast, by Country, 2023–2031
        10.6.1. U.S.
        10.6.2. Canada
    10.7. Market Attractiveness Analysis
        10.7.1. By Product Type
        10.7.2. By Wound Type
        10.7.3. By End-user
        10.7.4. By Country
11. Europe Advanced Wound Care Management Market Analysis and Forecast
    11.1. Introduction
    11.2. Key Findings
    11.3. Market Value Forecast, by Product Type, 2023–2031
        11.3.1. Moist Wound Dressings
            11.3.1.1. Foam Dressings
            11.3.1.2. Hydrocolloid Dressings
            11.3.1.3. Hydrogel Dressings
            11.3.1.4. Alginate Dressings
            11.3.1.5. Collagen Dressings
            11.3.1.6. Others
        11.3.2. Antimicrobial Dressings
            11.3.2.1. Silver Dressings
            11.3.2.2. Non-silver Dressings
        11.3.3. Active Wound Care
            11.3.3.1. Artificial Skin Substitutes
            11.3.3.2. Autografts
            11.3.3.3. Growth Factors
        11.3.4. Therapy Devices
            11.3.4.1. Negative Pressure Wound Therapy
            11.3.4.2. Oxygen and Hyperbaric Oxygen Equipment
            11.3.4.3. Pressure Relief Devices
            11.3.4.4. Electromagnetic Therapy Devices
            11.3.4.5. Others
    11.4. Market Value Forecast, by Wound Type, 2023–2031
        11.4.1. Acute Wound
            11.4.1.1. Surgical & Traumatic Wounds
            11.4.1.2. Burns
        11.4.2. Chronic Wound
            11.4.2.1. Infectious Wounds & Other Ischemic Wounds
            11.4.2.2. Ulcers
                11.4.2.2.1. Pressure Ulcer
                11.4.2.2.2. Diabetic Foot Ulcer
                11.4.2.2.3. Arterial & Venous Ulcer
                11.4.2.2.4. Other Ulcers
    11.5. Market Value Forecast, by End-user, 2023–2031
        11.5.1. Hospitals & Clinics
        11.5.2. Ambulatory Surgical Centers (ASCs)
        11.5.3. Home Health Care
        11.5.4. Others
    11.6. Market Value Forecast, by Country/Sub-region, 2023–2031
        11.6.1. Germany
        11.6.2. U.K.
        11.6.3. France
        11.6.4. Italy
        11.6.5. Spain
        11.6.6. Rest of Europe
    11.7. Market Attractiveness Analysis
        11.7.1. By Product Type
        11.7.2. By Wound Type
        11.7.3. By End-user
        11.7.4. By Country/Sub-region
12. Asia Pacific Advanced Wound Care Management Market Analysis and Forecast
    12.1. Introduction
    12.2. Key Findings
    12.3. Market Value Forecast, by Product Type, 2023–2031
        12.3.1. Moist Wound Dressings
            12.3.1.1. Foam Dressings
            12.3.1.2. Hydrocolloid Dressings
            12.3.1.3. Hydrogel Dressings
            12.3.1.4. Alginate Dressings
            12.3.1.5. Collagen Dressings
            12.3.1.6. Others
        12.3.2. Antimicrobial Dressings
            12.3.2.1. Silver Dressings
            12.3.2.2. Non-silver Dressings
        12.3.3. Active Wound Care
            12.3.3.1. Artificial Skin Substitutes
            12.3.3.2. Autografts
            12.3.3.3. Growth Factors
        12.3.4. Therapy Devices
            12.3.4.1. Negative Pressure Wound Therapy
            12.3.4.2. Oxygen and Hyperbaric Oxygen Equipment
            12.3.4.3. Pressure Relief Devices
            12.3.4.4. Electromagnetic Therapy Devices
            12.3.4.5. Others
    12.4. Market Value Forecast, by Wound Type, 2023–2031
        12.4.1. Acute Wound
            12.4.1.1. Surgical & Traumatic Wounds
            12.4.1.2. Burns
        12.4.2. Chronic Wound
            12.4.2.1. Infectious Wounds & Other Ischemic Wounds
            12.4.2.2. Ulcers
                12.4.2.2.1. Pressure Ulcer
                12.4.2.2.2. Diabetic Foot Ulcer
                12.4.2.2.3. Arterial & Venous Ulcer
                12.4.2.2.4. Other Ulcers
    12.5. Market Value Forecast, by End-user, 2023–2031
        12.5.1. Hospitals & Clinics
        12.5.2. Ambulatory Surgical Centers (ASCs)
        12.5.3. Home Health Care
        12.5.4. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2023–2031
        12.6.1. China
        12.6.2. Japan
        12.6.3. India
        12.6.4. Australia & New Zealand
        12.6.5. Rest of Asia Pacific
    12.7. Market Attractiveness Analysis
        12.7.1. By Product Type
        12.7.2. By Wound Type
        12.7.3. By End-user
        12.7.4. By Country/Sub-region
13. Latin America Advanced Wound Care Management Market Analysis and Forecast
    13.1. Introduction
    13.2. Key Findings
    13.3. Market Value Forecast, by Product Type, 2023–2031
        13.3.1. Moist Wound Dressings
            13.3.1.1. Foam Dressings
            13.3.1.2. Hydrocolloid Dressings
            13.3.1.3. Hydrogel Dressings
            13.3.1.4. Alginate Dressings
            13.3.1.5. Collagen Dressings
            13.3.1.6. Others
        13.3.2. Antimicrobial Dressings
            13.3.2.1. Silver Dressings
            13.3.2.2. Non-silver Dressings
        13.3.3. Active Wound Care
            13.3.3.1. Artificial Skin Substitutes
            13.3.3.2. Autografts
            13.3.3.3. Growth Factors
        13.3.4. Therapy Devices
            13.3.4.1. Negative Pressure Wound Therapy
            13.3.4.2. Oxygen and Hyperbaric Oxygen Equipment
            13.3.4.3. Pressure Relief Devices
            13.3.4.4. Electromagnetic Therapy Devices
    13.4. Market Value Forecast, by Wound Type, 2023–2031
        13.4.1. Acute Wound
            13.4.1.1. Surgical & Traumatic Wounds
            13.4.1.2. Burns
        13.4.2. Chronic Wound
            13.4.2.1. Infectious Wounds & Other Ischemic Wounds
            13.4.2.2. Ulcers
                13.4.2.2.1. Pressure Ulcer
                13.4.2.2.2. Diabetic Foot Ulcer
                13.4.2.2.3. Arterial & Venous Ulcer
                13.4.2.2.4. Other Ulcers
    13.5. Market Value Forecast, by End-user, 2023–2031
        13.5.1. Hospitals & Clinics
        13.5.2. Ambulatory Surgical Centers (ASCs)
        13.5.3. Home Health Care
        13.5.4. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2023–2031
        13.6.1. Brazil
        13.6.2. Mexico
        13.6.3. Rest of Latin America
    13.7. Market Attractiveness Analysis
        13.7.1. By Product Type
        13.7.2. By Wound Type
        13.7.3. By End-user
        13.7.4. By Country/Sub-region
14. Middle East & Africa Advanced Wound Care Management Market Analysis and Forecast
    14.1. Introduction
    14.2. Key Findings
    14.3. Market Value Forecast, by Product Type, 2023–2031
        14.3.1. Moist Wound Dressings
            14.3.1.1. Foam Dressings
            14.3.1.2. Hydrocolloid Dressings
            14.3.1.3. Hydrogel Dressings
            14.3.1.4. Alginate Dressings
            14.3.1.5. Collagen Dressings
            14.3.1.6. Others
        14.3.2. Antimicrobial Dressings
            14.3.2.1. Silver Dressings
            14.3.2.2. Non-silver Dressings
        14.3.3. Active Wound Care
            14.3.3.1. Artificial Skin Substitutes
            14.3.3.2. Autografts
            14.3.3.3. Growth Factors
        14.3.4. Therapy Devices
            14.3.4.1. Negative Pressure Wound Therapy
            14.3.4.2. Oxygen and Hyperbaric Oxygen Equipment
            14.3.4.3. Pressure Relief Devices
            14.3.4.4. Electromagnetic Therapy
    14.4. Market Value Forecast, by Wound Type, 2023–2031
        14.4.1. Acute Wound
            14.4.1.1. Surgical & Traumatic Wounds
            14.4.1.2. Burns
        14.4.2. Chronic Wound
            14.4.2.1. Infectious Wounds & Other Ischemic Wounds
            14.4.2.2. Ulcers
                14.4.2.2.1. Pressure Ulcer
                14.4.2.2.2. Diabetic Foot Ulcer
                14.4.2.2.3. Arterial & Venous Ulcer
                14.4.2.2.4. Other Ulcers
    14.5. Market Value Forecast, by End-user, 2023–2031
        14.5.1. Hospitals & Clinics
        14.5.2. Ambulatory Surgical Centers (ASCs)
        14.5.3. Home Health Care
        14.5.4. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2023–2031
        14.6.1. GCC Countries
        14.6.2. South Africa
        14.6.3. Rest of Middle East & Africa
    14.7. Market Attractiveness Analysis
        14.7.1. By Product Type
        14.7.2. By Wound Type
        14.7.3. By End-user
        14.7.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competitive Matrix (by Tier and Size of Companies)
    15.2. Market Share Analysis, by Company (2022)
    15.3. Company Profiles
        15.3.1. Smith+Nephew
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Financial Overview
            15.3.1.5. Strategic Overview
        15.3.2. Mölnlycke Health Care AB
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Financial Overview
            15.3.2.5. Strategic Overview
        15.3.3. ConvaTec Inc.
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Financial Overview
            15.3.3.5. Strategic Overview
        15.3.4. B. Braun SE
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Financial Overview
            15.3.4.5. Strategic Overview
        15.3.5. Coloplast A/S
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Financial Overview
            15.3.5.5. Strategic Overview
        15.3.6. 3M
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. SWOT Analysis
            15.3.6.4. Financial Overview
            15.3.6.5. Strategic Overview
        15.3.7. Integra LifeSciences
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. SWOT Analysis
            15.3.7.4. Financial Overview
            15.3.7.5. Strategic Overview
        15.3.8. PAUL HARTMANN AG
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Financial Overview
            15.3.8.5. Strategic Overview
        15.3.9. Cardinal Health
            15.3.9.1. Company Overview
            15.3.9.2. Product Portfolio
            15.3.9.3. SWOT Analysis
            15.3.9.4. Financial Overview
            15.3.9.5. Strategic Overview
        15.3.10. Hollister Incorporated
            15.3.10.1. Company Overview
            15.3.10.2. Product Portfolio
            15.3.10.3. SWOT Analysis
            15.3.10.4. Financial Overview
            15.3.10.5. Strategic Overview
        15.3.11. Organogenesis Inc.
            15.3.11.1. Company Overview
            15.3.11.2. Product Portfolio
            15.3.11.3. SWOT Analysis
            15.3.11.4. Financial Overview
            15.3.11.5. Strategic Overview
        15.3.12. Medline Industries, LP
            15.3.12.1. Company Overview
            15.3.12.2. Product Portfolio
            15.3.12.3. SWOT Analysis
            15.3.12.4. Financial Overview
            15.3.12.5. Strategic Overview
        15.3.13. Essity Health & Medical
            15.3.13.1. Company Overview
            15.3.13.2. Product Portfolio
            15.3.13.3. SWOT Analysis
            15.3.13.4. Financial Overview
            15.3.13.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			